Results 191 to 200 of about 338,723 (234)

Loss of significant association between high-sensitivity C-reactive protein (hs-CRP) and metabolic syndrome after adjustment for waist circumference found in 2022 Korea National Health and Nutrition Examination Survey data. [PDF]

J Physiol Anthropol
Kim BM, Ryu SY, Han MA, Choi SW.
europepmc   +1 more source

Inflammatory Markers and Aortic Aneurysms: Exploring the Role of Hs-CRP and MHR in Ascending Aortic Aneurysm Development. [PDF]

Int J Gen Med
Köprülü D, Hassan MO, Atmaca H, Albayrak S, Işcanlı E.   +4 more
europepmc   +1 more source

Association of Estimated Glomerular Filtration Rate (eGFR) and High-Sensitivity C-Reactive Protein (Hs-CRP) with the Risk of New-Onset Atrial Fibrillation in Patients with Diabetes. [PDF]

J Inflamm Res
Liu Y, Liu H, Sun D, Zheng Y, Tse G, Chen K, Qiu J, Wu S, Liu T.   +8 more
europepmc   +1 more source

Diagnostic efficacy of ACA, aβ2-GP1, hs-CRP, and Hcy for cerebral infarction and their relationship with the disease severity. [PDF]

Am J Transl Res
Shang X, Li J, Wang X, Zhang P.
europepmc   +1 more source

Nonlinear associations of the hs-CRP/HDL-C index with metabolic dysfunction-associated steatotic liver disease and advanced liver fibrosis in US adults: insights from NHANES 2017-2018. [PDF]

Sci Rep
Liang B, Qiu X, Huang J, Lu Y, Shen H, Ma J, Chen Y.   +6 more
europepmc   +1 more source

Autologous platelet rich plasma injection can be effective in the management of osteoarthritis of the knee: impact on IL-1 β, TNF-α, hs-CRP. [PDF]

J Orthop Surg Res
Qiao J, Guo X, Zhang L, Zhao H, He X.
europepmc   +1 more source

In vivo and in silico study of europinidin against streptozotocin-isoproterenol-induced myocardial damage via alteration of hs-CRP/CPK-MB/Caspase-3/Bcl-2 pathways. [PDF]

Sci Rep
Alharbi KS, Afzal M, Al-Abbasi FA, Moglad E, Al-Qahtani SD, Almalki NAR, Imam F, Sayyed N, Kazmi I.   +8 more
europepmc   +1 more source

To Estimate the Level of Homocysteine, Lipid Profile, and Lipid Ratio and Compare it with the Level of HS-CRP, Apo A, and ADMA in Coronary Artery Disease-Diagnosed Patients.

J Pharm Bioallied Sci
Singh SK, Jha RK, Ambad RS, Jha RK.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Baseline hs‐CRP predicts hypertension remission in metabolic syndrome

European Journal of Clinical Investigation, 2019
Inflammation, overweight and other cardiovascular risk factors might negatively impact on hypertension remission in metabolic syndrome (MetS), independently of the pharmacological treatment.
F. Carbone, E. Elia, M. Casula, A. Bonaventura, L. Liberale, M. Bertolotto, N. Artom, S. Minetti, F. Dallegri, P. Contini, D. Verzola, R. Pontremoli, F. Viazzi, G. Viviani, S. Bertolini, A. Pende, L. Pisciotta, F. Montecucco   +17 more
semanticscholar   +4 more sources